Hypoxen 250 mg 30 capsules
Plaquenil 200 mg 60 tablets
Tamiflu 75 mg 10 capsules
Sialis 5 mg 14 tablets
Semax nasal drops 0.1% 3 ml
Sildenafil 100 mg 20 tablets
Champix 1 mg 112 tablets
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
Piracetam 800 mg 30 tablets
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 100 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Neurontin 300 mg 50 capsules
Vestibo 16 mg 30 tablets
Deprim 30 tablets
Cerebrolysin 5 ml 5 vials
Convulex 500 mg 50 tablets
Mirapex 0.25 mg 30 tablets
neyrobion 3 ml 3 vials
Novo-passit 10 tablets
Persen 60 tablets
Pantogam 500mg 50 tablets
Zonegran 25 mg 14 tablets
Piracetam 400 mg 60 tablets
Ceraxon 1000 mg/4 ml 5 vials
Noben 30 mg 30 capsules
Afobazol 10 mg 60 tablets
Noopept 10 mg 50 tablets
Mirapex 0.375 mg 10 tablets
Lotosonik 10 tablets
Persen 20 tablets
Cerebrolysin 10 ml 5 vials
Actovegin 200 mg 50 tablets
Cerebrolysin 2 ml 10 vials
Tebantin 300 mg 50 capsules
Antisten 35 mg 60 tablets
Manufacturer: OZONE
Country of origin: Russia
General description: antihypoxic agent
Pharmacological action
Has antihypoxic effect. By directly affecting cardiomyocytes and neurons of the brain, the drug optimizes their metabolism and function. The cytoprotective effect is caused by an increase in the energy potential, activation of oxidative decarboxylation and rationalization of oxygen consumption (enhancement of glycolysis and blockade of fatty acid oxidation).
Trimetazidine supports myocardial contractility, prevents a decrease in the intracellular content of ATP and phosphocreatinine. In conditions of acidosis normalizes the functioning of ion channels of membranes, prevents the accumulation of calcium and sodium ions in cardiomyocytes, normalizes the intracellular content of potassium ions.
Reduces intracellular acidosis and increased phosphate content, due to myocardial ischemia and reperfusion. Prevents the damaging effect of free radicals, preserves the integrity of cell membranes, prevents the activation of neutrophils in the ischemic zone, prolongs the duration of the electrical potential, reduces the output of CKK from cells and the severity of ischemic myocardial damage.
Trimetazidine reduces the frequency of angina attacks, reduces the need for nitrate intake, after 2 weeks of use increases exercise tolerance, sharp fluctuations in blood pressure decrease. Reduces dizziness and noise in the ears of ischemic etiology. In vascular pathology, the eye restores the functional activity of the retina.
Indications
- IHD: prevention of angina attacks (in complex therapy);
- cochleovestibular disorders of ischemic nature, such as dizziness, tinnitus, hearing impairment;
- choreoretinal vascular disorders.


.